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Abstract
Background: This cross-sectional, questionnaire-based survey, conducted in Shanxi Province, China, evaluated the
knowledge of community physicians of secondary prevention of ischemic stroke and transient ischemic attacks (TIAs).
Methods: A total of 1910 physicians practicing at 832 community-based clinics, hospitals and other care centers in 11
prefectures of Shanxi Province completed the questionnaires between 1 July and 30 September 2013.
Results: Over 90 % of participants were aware of the most common risk factors for stroke, but lifestyle-related factors
were seen as of low or medium importance for secondary prevention. Only about 50 % of physicians were aware of
the existence of commonly used stroke scales, and fewer said that they would use those scales in their clinical practice.
There were slight differences in the responses to some of the questions on risk factors and stroke scales were
associated with the physicians’ gender, academic qualifications, practice duration and location. Less than half of the
participants were aware of the secondary prevention recommendations included in the most recent guidelines.
Conclusion: The survey revealed a huge gap in knowledge of current guidelines for secondary prevention of ischemic
stroke and TIA among the physicians surveyed. Continuing education and training of community physicians,
administered as a public health program, is needed to improve the healthcare of ischemic stroke and TIA patients.
Keywords: Ischemic stroke, Transient ischemic attack, Secondary prevention, Community physician
Background
The mortality of ischemic and hemorrhagic stroke is de-
creasing worldwide, resulting in an increase in the number
of stroke survivors, especially in low- and middle-income
countries [1]. Patients who have had an ischemic stroke or
transient ischemic attack (TIA) have a high risk of recur-
rence; and in Western countries, approximately 8–12 % of
patients experience a second event within the first year
after a stroke or TIA [2, 3]. The National Stroke Registry
of China reported that 17.7 % of 11,560 patients with
ischemic stroke or TIA, experienced a recurrence within
1 year [4]. This geographical difference may be partly
explained by the relatively high prevalence of intracranial
large-artery disease in the Chinese compared with
Western populations and the particularly high risk of
recurrent ischemic stroke with that etiology. On the
other hand, it might also be attributed to gaps in the
professional education of practicing physicians and
their familiarity with current guidelines for secondary
prevention in China [5]. Such gaps would hinder timely
and accurate risk evaluation, stratification, and optimal
medical management, as well as the best use of anti-
platelet, anticoagulant, or interventional/surgical ther-
apies, which are all important for secondary prevention.
Improved knowledge and awareness would be expected
to result in a reduced risk of recurrence in stroke
patients [6, 7].
A large, nationwide survey of secondary stroke preven-
tion, conducted in 3489 Chinese general physicians and
neurologists, reported a lack of adequate awareness of
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the Chinese National Guidelines for Prevention of
Ischemic Stroke and Transient Ischemic Attack [8]
The survey participants were either general practi-
tioners or specialists [5], but their responses did not
accurately represent the level of professional knowledge
that many practicing Chinese community physicians have.
For example, in Shanxi Province, located in the center of
the Yellow River Valley of northern China, all community
physicians are involved in the care of stroke patients.
However, little is known of their knowledge of the aspects
of stroke relevant to recurrence, and no standardized
training or continuing education programs in the area of
stroke are currently available to them. This survey of the
community physicians in Shanxi Province, where our
medical university is located, was conducted to identify
existing gaps in the professional knowledge of stroke. The
results may assist in the implementation of appropriate
continuing education programs intended to reduce the
risk of recurrent stroke.
Methods
Ethics statement
This cross-sectional study surveyed currently licensed
physicians practicing in community-based clinics, hospi-
tals and other care centers in Shanxi Province, China,
and was approved by the Ethics Committee of Shanxi
Medical University. A questionnaire with selected re-
sponse questions was mailed to all physicians practicing
in clinics in the 11 prefectures of Shanxi Province, and
all of those who responded provided written, informed
consent before completing the survey.
Questionnaire survey
The Shanxi Provincial Health Bureau sent the question-
naires to the local health authorities of 11 prefectures in
the province, which then forwarded them to all the
general physicians in their communities. A pilot survey
of 10 physicians in two communities was conducted be-
fore initiation of the study to estimate the response and
questionnaire completion rates of potential participants.
The participants were asked to provide personal infor-
mation including their age, gender, and demographic in-
formation, including the number of years in practice and
their academic qualifications. Questions on knowledge
of secondary prevention of ischemic stroke and TIA were
developed to reflect the most recent Chinese stroke
rehabilitation management [9] and American Heart Asso-
ciation/American Stroke Association (AHA/ASA) guide-
lines [7, 10]. The questionnaire covered three major areas.
The first part consisted of multiple-choice questions about
common risk factors of ischemic stroke is shown in Fig. 1,
including obesity, limited physical activity, smoking, exces-
sive drinking, histories of hypertension, diabetes, atrial fib-
rillation, atherosclerotic coronary/carotid artery diseases,
prior TIA/minor stroke, dyslipidemia (elevated total choles-
terol, low-density lipoprotein cholesterol, or triglycerides)
and hyperhomocysteinemia [7, 10]. The participants were
asked for their awareness of these risk factors, and to rate
Fig. 1 Box-and-whisker plots showing the importance of individual risk factors of ischemic stroke as rated on a scale from 1 to 9 by community
physicians, with 9 as most important. CAD, coronary artery disease; TIA, transient ischemic attack; LDL-C, low-density lipoprotein cholesterol
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each risk factor on a scale of 1 to 9, with 9 indicating the
highest importance. The second part consisted of “yes or
no” questions related to the awareness of commonly used
clinical scores to evaluate the severity or prognosis of
ischemic stroke or TIA. The questions were based on the
National Institutes of Health Stroke Scale (NIHSS)
[11] and its Chinese version (C-NIHSS) [12], and the
Scandinavian Stroke Scale (SSS) [13], as well as the
ABCD score (A, age; B, blood pressure; C, clinical features;
and D, duration of symptoms) for TIA [14]. The physicians
were also asked if they would use those scores to evaluate
any suspected ischemic stroke or TIA cases. The third part
examined knowledge of acute treatment and secondary
prevention of ischemic stroke, and consisted of multiple-
choice questions on aspects such as thrombolytic,
antiplatelet, anticoagulant, and antihypertensive therapies.
Statistical analysis
Descriptive statistics were used to summarize the study
results. Age and number of years in practice were
expressed as means ± SD. Ordinal variables (e.g., scoring
of the importance of risk factors) were expressed as
medians with interquartile (IQR) ranges and box-and-
whisker plots. Categorical demographic variables and
responses to the multiple-choice and “yes or no” items
in the questionnaire were given as numbers (percent-
ages). The number of community physicians who com-
pleted and returned the questionnaire was considered as
the denominator for all proportion calculations. Bar
charts were used to reveal the community physicians’
awareness of common risk factors and scoring systems
for ischemic stroke or TIA. Chi-square tests were per-
formed to determine the significance of differences in
the awareness of risk factors and stroke scales in male
and female physicians and in physicians with different
academic qualifications, practice durations, and practice
locations. All statistical analyses were carried out by
SPSS version 13.0 (SSPS Inc, Chicago, USA). Two-sided
P-values <0.05 were considered statistically significant.
Results
Participant demographics
A total of 1,918 questionnaires were mailed to physicians
at 832 community-based clinics, hospitals and other care
centers in 11 prefectures of Shanxi Province, China,
from 1 July to 30 September 2013. Of these, 1,910 were
completed and returned, for a response rate of over
99 %. Of the participating physicians, 780 (40.8 %) were
men, and 1130 (59.2 %) were women. Their mean age
was 43 ± 14 years, and they had practiced for a mean of
15 ± 15 years. The highest academic qualification in this
group of community physicians was a 3-year junior
college degree in medicine, earned by 1346 participants
(70.5 %), 455 (23.8 %) had a 4-year bachelor’s degree,
and 15 (0.8 %) had an additional 2 to 3-year master’s de-
gree. Ninety-four participants (4.9 %) were traditional
Chinese medicine practitioners who had been trained by
their predecessors and did not have a formal tertiary
qualification.
Knowledge of common risk factors of ischemic stroke
Awareness of common risk factors for ischemic stroke,
as measured by the questionnaire, is shown in Table 1.
More than 90 % the surveyed physicians were aware of
the risk factors. However, nearly 30 % did not consider
limited physical activity as a stroke risk; and obesity,
smoking, and excessive alcohol consumption were under
appreciated, as indicated by median scores of 5 or 6 on a
scale in which 9 indicated the highest importance.
Differences in the perceived importance of individual
stroke-risk factors that were reported by male and
female physicians and by physicians with different aca-
demic qualifications, duration and location of practice
are also shown in Table 1. There was no significant differ-
ence between male and female physicians in awareness of
the surveyed risk factors, except for atherosclerotic coron-
ary artery disease, which female physicians scored as being
more important than male physicians did (P = 0.013).
Physicians with shorter practice durations were more
aware of the importance of limited physical activity and
hyperhomocysteinemia as risk factors than were physi-
cians in practice for longer periods of time. The degree of
awareness of a number of risk factors were significantly
different in community physicians with different academic
qualifications or practice location, but the absolute differ-
ences in percentage were small and may not be meaning-
ful in practice.
Knowledge of commonly used stroke scales
Awareness of commonly used stroke and TIA evaluation
scores and their willingness to use them in their prac-
tices are shown in Table 2. Only 39.8 %, 55.0 % and
20.0 % of the community physicians, respectively, were
aware of using the NIHSS, C-NIHSS, and SSS scores to
evaluate the neurological deficits of stroke or TIA
patients, and only 45.4 % of the physicians indicated they
would use NIHSS or C-NIHSS criteria to evaluate
potential stroke patients in their clinical practice. Only
46.9 % of the physicians were aware of the ABCD score,
and only 18.9 % of them would use it to evaluate poten-
tial TIA patients in their clinical practice.
There was no significant difference between male and
female physicians in their awareness of or willingness to
use these scales (Table 2). The awareness of SSS and
C-NIHSS differed among physicians with different
practice duration and location as well as in those with the
highest academic qualification and traditional Chinese
medicine practitioners. There was a trend toward increased
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Table 1 Gender, academic qualifications, practice duration and location and awareness of common risk factors for ischemic strokea
Total Gender Highest academic qualification Practice duration Location of practicing













P value* <10 years 10–20
years
>20 years P value* Rural Urban P value*
(n = 780) (n = 1,130) (n = 1,346) (n = 455) (n = 15) (n = 650) (n = 917) (n = 343) (n = 454) (n = 1,456)
Obesity 96.7 96.6 96.9 0.807 96.5 96.8 100 100 0.321 96.5 96.4 97.4 0.614 98.0 96.4 0.154
Limited physical
activity
73.2 73.3 73.0 0.884 74.1 67.6 66.7 76.8 0.070 76.3 73.2 68.4 0.037 74.9 72.7 0.431
Smoking 96.3 96.6 96.0 0.475 96.1 95.5 100 98.8 0.457 96.9 95.8 96.7 0.561 97.4 96.0 0.219
Excessive drinking 94.3 93.2 95.0 0.123 93.5 95.8 93.3 98.8 0.108 95.5 94.7 92.0 0.069 93.0 94.6 0.239
Hypertension 99.7 99.6 99.8 0.402 99.7 99.8 100 100 0.969 99.8 99.5 99.8 0.738 99.7 99.7 0.982
Diabetes 96.1 96.7 95.7 0.321 95.6 97.3 86.7 96.4 0.137 95.8 96.4 95.3 0.669 92.5 97.0 <0.001
Atrial fibrillation 92.0 90.8 92.7 0.152 91.5 93.5 93.3 87.7 0.308 89.5 91.9 92.4 0.278 89.1 92.7 0.028
Atherosclerotic CAD 95.2 93.6 96.2 0.013 95.1 94.8 93.3 96.3 0.930 92.7 96.5 93.6 0.930 94.7 95.3 0.648
Carotid plaque 96.7 95.9 97.2 0.146 95.9 98.2 100 100 0.032 95.2 96.4 97.6 0.170 96.5 96.7 0.841
Carotid stenosis 94.9 94.3 95.2 0.408 93.9 96.7 93.3 97.5 0.115 92.6 95.7 94.5 0.090 92.6 95.4 0.037
Prior TIA 98.0 97.2 98.5 0.056 97.5 99.5 93.3 96.4 0.041 98.1 97.9 97.2 0.616 98.2 97.9 0.720
Prior minor stroke 98.0 97.7 98.1 0.545 97.9 98.0 93.3 97.5 0.665 97.6 97.6 98.1 0.848 99.4 97.6 0.038
Elevated total
cholesterol
98.3 97.9 98.5 0.462 97.5 99.8 100 100 0.015 97.9 98.1 98.6 0.715 99.1 98.0 0.163
Elevated LDL-C 92.2 92.4 92.1 0.927 91.8 94.1 80.0 89.0 0.092 93.5 91.6 89.5 0.121 91.8 92.3 0.761
Elevated
triglycerides
98.0 97.8 98.2 0.604 97.3 99.5 100 100 0.021 97.6 97.8 98.1 0.872 99.1 97.8 0.100
Hyperhomocysteinemia 89.9 88.4 90.9 0.094 89.1 92.2 80.0 86.8 0.149 91.1 90.6 84.7 0.004 87.9 90.4 0.182
TCM traditional Chinese medicine, CAD coronary artery disease, TIA transient ischemic attack, LDL-C low-density lipoprotein cholesterol
*Chi-square test, P < 0.05 indicates a significant difference in awareness between groups.













Table 2 Gender, academic qualification, practice duration, and location and awareness of and willingness to use commonly used stroke-scoring scalesa
Total Gender Highest academic qualification Practice duration Location of practicing










P value* <10 years 10–20
years
>20 years P value* Rural Urban P value*
(n = 780) (n = 1,130) (n = 1,346) (n = 455) (n = 15) (n = 94) (n = 650) (n = 917) (n = 343) (n = 454) (n = 1,456)
Awareness of
NIHSS
39.8 42.2 38.4 0.120 38.3 43.0 50.0 32.0 0.171 37.8 38.7 40.9 00.643 36.8 40.7 0.192
Awareness of
C-NIHSS




45.4 46.0 45.0 0.721 46.3 41.7 50 41.1 0.390 41.8 45.7 50.0 0.113 50.0 44.3 0.098
Awareness
of SSS
20.0 21.4 19.2 0.244 18.0 24.5 13.3 19.0 0.033 18.9 16.1 22.1 0.041 21.6 19.6 0.404
Awareness of
ABCD score




18.9 19.8 18.4 0.730 18.8 17.2 23.1 13.3 <0.001 17.8 18.0 19.7 0.550 18.7 19.0 0.072
TCM traditional Chinese medicine, NIHSS National Institutes of Health Stroke Scale, C-NIHSS Chinese version of NIHSS, SSS Scandinavian Stroke Scale, ABCD acronyms: A Age, B Blood pressure, C Clinical features, D
Duration of symptoms, TIA transient ischemic attack
*Chi-square test













awareness of, and willingness to use, the NIHSS/C-NIHSS
among those with bachelor’s or master’s degrees than
among those without a tertiary qualification. Physicians
with a junior college or a bachelor’s degree had more
knowledge of the ABCD score than those with a mas-
ter’s degree.
Knowledge of secondary prevention strategies in ischemic
stroke or TIA
The responses to questions on acute treatment and sec-
ondary prevention of ischemic stroke or TIA are shown
in Table 3. Only 14.4 % of the community physicians
were aware of the most recently recommended 4.5-h time
window for intravenous thrombolytic therapy of acute
ischemic stroke (Q1), while 35.9 % chose the 3-h time
window that was included in the previous international
guidelines [15]. Only around 50 % of the physicians were
aware of the recommendations for antihypertensive ther-
apy in ischemic stroke or TIA patients with elevated blood
pressure (Q2, Q3) contained in the most recent guideline
[7]. A total of 65.3 % of the physicians chose oral anticoag-
ulants as the first-choice medication for cardioembolic
ischemic stroke or TIA patients with atrial fibrillation
(Q5), and 78.9 % were aware of the target range of the
international normalized ratio (INR, Q6). Only 26.4 %
were aware that the guidelines recommend the use of as-
pirin alone for patients who are unable to take oral antico-
agulants (Q7) [7], and over half (52.8 %) chose clopidogrel
plus aspirin. A majority of physicians (67.0 %) would use
antiplatelet medications to prevent recurrence of noncar-
dioembolic ischemic stroke, TIA, or other cardiovascular
events (Q10). Only 40.5 % were aware that dual antiplate-
let therapy with aspirin plus clopidogrel (Q11) is not
currently recommended for routine secondary prevention
after ischemic stroke or TIA [7]. In addition, only 11.4 %
were aware of the recommendation for reducing homo-
cysteine level (Q12), and 46.8 % were aware of the recom-
mendation for postmenopausal hormone therapy (Q13) in
ischemic stroke or TIA patients.
Discussion
We used a questionnaire to survey the knowledge of
acute treatment and secondary prevention for ischemic
stroke and TIA in a group of 1910 community physi-
cians with an average of 15 years of practice in Shanxi
Province, China. The responses revealed a huge gap
among the participants in knowledge and clinical appli-
cation of the most recent Chinese and AHA/ASA treat-
ment guidelines for secondary prevention of ischemic
stroke and TIA. The results demonstrate the need to im-
plement a new policy for continuing medical education
and training in advances in the care of stroke and TIA
patients. Keeping up-to-date with new developments in
patient care and secondary prevention would reduce the
risk of stroke recurrence.
Most community physicians were aware of the com-
mon risk factors for ischemic stroke and TIA. However,
despite the extensive evidence that lifestyle modifications
have beneficial effects on multiple stroke risk factors,
many of the physicians surveyed considered lifestyle-
related risk factors to be less important than the other
modifiable or nonmodifiable risk factors. Gender, aca-
demic level, practice duration, and practice location all
affected physician awareness of some of the risk factors
surveyed, but the differences were not significant. Know-
ledge of commonly used stroke scales was severely inad-
equate regardless of gender, academic qualifications,
practice duration, or practice location. Approximately
half the physicians were aware of NIHSS, C-NIHSS, SSS,
and ABCD scores, but fewer than half were willing to
use those scores to evaluate stroke or TIA patients. In
particular, timely use of the ABCD score in TIA patients
could help to identify those at high risk of a subsequent
stroke in the first few hours and days after TIA onset
[14]. Standard procedures stipulate that such patients
should be promptly transferred or referred to a tertiary
hospital with a stroke care center. However, insufficient
knowledge about use of the ABCD score may severely
hinder timely risk stratification of TIA patients, espe-
cially for those whose symptoms have resolved and who
seek help from community physicians without immedi-
ately going to the tertiary hospitals with stroke care
centers. The community physicians participating in this
study did not possess adequate knowledge of the sec-
ondary prevention measures recommended by the latest
guidelines. Long-term adherence to these measures is
crucial for preventing recurrent stroke and other cardio-
vascular events in those patients with post-ischemic
stroke or TIA [7].
A study of over 2000 ischemic stroke or TIA patients
discharged from 106 hospitals participating in the AHA’s
Get With The Guidelines stroke program in the United
States between July 2006 and July 2008, found that
87.1 %, 68.2 %, and 87.9 %, respectively, continued to
adhere to antiplatelet, anticoagulant (warfarin), and anti-
hypertensive medications at 1 year after discharge [16].
Since then, the Get With The Guidelines stroke program
has significantly enhanced the quality of care of stroke
patients in the United States, including secondary pre-
vention [17]. Although similar programs have been
established in China, (e.g., the China National Stroke
Registry and the National Center for Stroke Care Quality
Control) [18, 19], there are still huge evidence-based
practice gaps in the secondary prevention of ischemic
stroke and TIA. The long-term adherence to secondary
prevention measures in Chinese stroke patients is lower
than that reported in the American studies, especially in
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Table 3 Numbers and proportions of community physicians’ (N = 1,910) answers to multiple-choice questions on acute treatment
and secondary prevention of ischemic stroke or TIAa
Questions & Answers Numbers Proportions
Q1. For eligible ischemic stroke patients, what is the recommended time window for intravenous fibrinolytic therapy with rtPA?
3 hours 686 35.9 %
4 hours 180 9.4 %
4.5 hoursb 275 14.4 %
6 hours 769 40.3 %
Q2. In secondary prevention for ischemic stroke or TIA, which of the following antihypertensive recommendations should be
used in patients with elevated blood pressure?
20/15 mmHg 330 17.3 %
15/10 mmHg 600 31.4 %
10/5 mmHgb 945 49.5 %
5/0 mmHg 35 1.8 %
Q3. If necessary to prevent recurrent stroke or other vascular events in ischemic stroke or TIA patients, when is it
recommended to initiate antihypertensive therapy?
Immediately 344 18.0 %
Beyond 24 hoursb 1,112 58.2 %
Beyond 1 week 260 13.6 %
Beyond 2 weeks 194 10.2 %
Q4. What is the approximate percentage of cardiogenic cerebral embolism in all ischemic strokes?
5 % 319 16.7 %
10 % 386 20.2 %
15 % 405 21.2 %
20%b 800 41.9 %
Q5. For ischemic stroke or TIA patients with AF, what is the recommended first-choice medication, if no contraindication
exists?
Antiplatelet medication 524 27.4 %
Oral anticoagulantb 1,247 65.3 %
Defibrase 105 5.5 %
Others, i.e., traditional Chinese medicine 34 1.8 %
Q6. What is the target INR for ischemic stroke or TIA patients with AF receiving anticoagulation with a vitamin K antagonist?
1–2 180 9.4 %
2–3b 1,507 78.9 %
3–4 195 10.2 %
4–5 28 1.5 %
Q7. For ischemic stroke or TIA patients with AF who are unable to take oral anticoagulants, what medication is recommended?
Aspirin aloneb 504 26.4 %
Clopidogrel alone 398 20.8 %
Combination of clopidogrel and aspirin 1,008 52.8 %
Do not use any other medications 0 0
Q8. For ischemic stroke or TIA with acute myocardial infarction complicated by left ventricular mural thrombus formation i
dentified by echocardiography or other cardiac imaging techniques, for at least how long should the patients be treated
with oral anticoagulation?
3 monthsb 514 26.9 %
6 months 760 39.8 %
9 months 120 6.3 %
12 months 516 27.0 %
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the use of anticoagulant medications. A national clinical
trial with over 3000 ischemic stroke or TIA patients
discharged from 47 hospitals in China, reported that at
1-year post stroke, 81.1 %, 36.1 % and 68.6 % of the
patients, respectively, adhered to the antiplatelet, anti-
coagulant, and antihypertensive medications prescribed
at discharge.cs [20] Since community physicians often
prescribe daily medications for patients who have had an
ischemic stroke or TIA, more education and communi-
cation programs are needed to equip them with better
knowledge in this area. Moreover, providing community
physicians with ready-to-use tools such as portable refer-
ence cards outlining stroke scores and essential second-
ary prevention recommendations of current guidelines,
may help to narrow the evidence-based practice gaps in
community care centers.
The strengths of this study are that all the 11 prefec-
tures of Shanxi Province were surveyed and that the re-
sponse rate was high, mainly because the physicians, as
government employees, viewed participation as mandatory.
Use of a simplified questionnaire that did not cover all the
essential secondary prevention measures for ischemic
stroke or TIA patients (e.g., management of lipid profiles
and diabetes) was a study limitation. In the near future,
independently designed studies of this kind that are nation-
wide in scope, or incorporated into national stroke registry
programs, would further describe the gaps between com-
munity physician practices and evidence-based guidelines.
The results of those studies would help in the design, and
initiation of relevant education and support programs in
China.
Conclusions
This study revealed a huge gap among community phy-
sicians in the knowledge and clinical practice of the rec-
ommendations contained in the most recent Chinese and
AHA/ASA guidelines for secondary prevention of ische-
mic stroke and TIA. There is a great need for education
and training of the community physicians in this area.
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Table 3 Numbers and proportions of community physicians’ (N = 1,910) answers to multiple-choice questions on acute treatment
and secondary prevention of ischemic stroke or TIAa (Continued)
Q9. For ischemic stroke or TIA patients with rheumatic mitral valve disease, is long-term warfarin therapy recommended whether
or not AF is present?
Yesb 1,215 63.6 %
No 487 25.5 %
No idea 208 10.9 %
Q10. For patients with noncardioembolic ischemic stroke or TIA, what medications are recommended to reduce the risk of
recurrent stroke and other cardiovascular events?
Antiplateletsb 1,280 67.0 %
Oral anticoagulants 29 26.1 %
Traditional Chinese medicine 131 6.9 %
Q11. Is aspirin plus clopidogrel recommended for routine secondary prevention after ischemic stroke or TIA?
Yes 886 46.4 %
Nob 774 40.5 %
No idea 250 13.1 %
Q12. Is there evidence that reducing homocysteine levels prevents stroke recurrence in ischemic stroke or TIA patients?
Yes 1,322 69.2 %
Nob 217 11.4 %
No idea 371 19.4 %
Q13. Is postmenopausal hormone therapy recommended for women with ischemic stroke or TIA?
Yes 562 29.4 %
Nob 894 46.8 %
No idea 454 23.8 %
AF atrial fibrillation, INR international normalized ratio, rtPA recombinant tissue-type plasminogen activator, TIA transient ischemic attack
aThe questions and answers were designed to reflect relevant American Heart Association/American Stroke Association guidelines (AHA/ASA) [7, 10]
bRecommendations from relevant AHA/ASA guidelines [7, 10]
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